ANDA 84246, held by Everylife. Cortisone Acetate.
As of Nov 15, 2026, ANDA 84246 (Cortisone Acetate), held by Everylife, was first approved by FDA on Jan 22, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cortisone Acetate25MG ยท tablet;oral | Cortisone Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
